Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Erleada
Erleada
J&J takes Aurobindo to court over potential Erleada generic
Endpoints
Tue, 05/31/22 - 11:53 pm
JNJ
Aurobindo
legal
generics
Erleada
J&J decides against Erleada+Zytiga combination prostate cancer filing
Pharmaforum
Tue, 04/20/21 - 11:02 am
JNJ
prostate cancer
Erleada
Zytiga
clinical trials
Janssen Shows 35% Drop in Mortality with Prostate Cancer Drug
BioSpace
Wed, 02/10/21 - 12:01 am
Janssen
JNJ
Erleada
prostate cancer
clinical trials
Pfizer, Astellas' Xtandi matches J&J's rival Erleada with new prostate cancer nod
Fierce Pharma
Mon, 12/16/19 - 10:37 pm
Pfizer
Astellas
Xtandi
prostate cancer
JNJ
Erleada
FDA
Updated Erleada Data Shows Reduced Risk of Death in Prostate Cancer Patients
BioSpace
Sat, 09/28/19 - 04:25 pm
Erleada
Janssen
JNJ
ESMO
prostate cancer
ASCO 2019 day one
Pharmaforum
Fri, 05/31/19 - 11:46 am
ASCO 2019
JNJ
Erleada
AstraZeneca
Merck
Lynparza
prostate cancer
Marketing J&J eyes prostate cancer boost as FDA accepts Erleada for real-time review
Fierce Pharma
Fri, 05/3/19 - 10:43 pm
JNJ
Erleada
FDA
prostate cancer
metastatic castration-resistant prostate cancer
J&J scores another PhIII win for Erleada as it continues to build a blockbuster franchise
Endpoints
Wed, 01/30/19 - 11:47 am
JNJ
Erleada
prostate cancer
metastatic prostate cancer
European Commission Approves Janssen's Erleada for Patients at High Risk of Developing Metastatic Prostate Cancer
CP Wire
Wed, 01/16/19 - 10:03 am
Janssen
JNJ
Erleada
prostate cancer
Europe
European Commission Approves Janssen's Erleada for Patients at High Risk of Developing Metastatic Prostate Cancer
Wed, 01/16/19 - 09:52 am
Janssen
JNJ
Erleada
prostate cancer
Pharma/Biotech Stocks to Watch This Prostate Cancer Month
Yahoo/Zacks.com
Sun, 09/16/18 - 02:16 pm
prostate cancer
JNJ
Zytiga
Erleada
Pfizer
Astellas
Xtandi
AbbVie
Lupron
Endocyte
Lu-PSMA-617
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
Thu, 03/22/18 - 09:21 am
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
New FDA transparency push begins with J&J's Erleada
Biopharma Dive
Wed, 03/21/18 - 11:29 pm
FDA
transparency
JNJ
Erleada
drug approvals